Measles elimination Dr. As’ad Ramlawi Palestine..

Slides:



Advertisements
Similar presentations
Under-5 Questionnaire Immunization Module. Global proportion of one year old children vaccinated against measles; Source: WHO UNICEF National.
Advertisements

MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop Questionnaire for Children Under Five: Immunization.
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
IPV IPV Rapidly produces high level of protective antibodies No risk of vaccine associated illness No interference from other enteroviruses. I.P.V. produces.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Role of the laboratory in disease surveillance
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Healthy People 2020 Progress Review: The Burden of Tuberculosis and Infectious Diseases in the U.S. and Abroad Appendix Slides National Center for Health.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Module 5 Recording and monitoring uptake of Inactivated Polio vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Health Status in Palestine
Polio eradication programme in India – Progress, Response and Issues for action Dr Ajay Khera Deputy Commissioner Ministry of Health & FW, Govt. of India.
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
Emergency Preparedness and Response Plan Dr. Ajay Khera Deputy Commissioner Ministry of Health & FW, Government of India.
An-Najah 2 nd Medical International Conference “ Evidence based advances in women healthcare” 8-10/10/2009 Nablus- Palestine.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
Expanded Program of Immunization Dr. Faten M. Rabie.
30th anniversary of starting EPI
First National Course on Public Health Emergency Management 12 – 23 March Muscat, Oman.
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
Epidemiology of Vaccine Preventable diseases in Iran
MEASLES MORTALITY REDUCTION IN INDIA Status and Future Plans.
Rash Decisions: The Colorado Experience with “Maybe Measles” Emily Spence Davizon, Colorado Department of Public Health and Environment.
Health Service Delivery Cluster Response to Typhoon Yolanda Center for Health Development- Western Visayas.
Laboratory Integration in Influenza Surveillance Dr Geethani Wickramasinghe NIC- Sri Lanka.
Progress of Polio Eradication in India, Current Risks & Actions taken on last IEAG report 24 th IEAG, New Delhi 15 March 2012 Dr. Ajay Khera Deputy Commissioner.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
E P I. EPI Coverage 2011 BMNS camp (Site 1)BMS camp (Site 2)
World Health Organization Eastern Mediterranean Region.
Sustaining Polio Eradication IEAG March 2012 The experience of polio-free countries with importations of WPV: Implications for India.
Thomas Clark, MD, MPH Centers for Disease Control and Prevention Immunization Program Managers Meeting November 16, 2010 Pertussis Epidemiology in the.
Global Overview of Measles & Rubella 11 th Annual Meeting The Measles Initiative Washington, DC th September, 2012.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
Eradication of Poliomyelitis Global & National Overview Goal : Complete interruption of wild poliovirus transmission Dr OR Goldie (State EPI Officer Punjab)
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
New vaccines, schedules, and target groups. Old schedule 1 dose of BCG 3 doses of DPT 3 doses of Oral Polio 1 dose of Measles.
New Delhi 10 August 2004 AEFI Communication: Bangladesh Experience 1 For every child Health, Education, Equality, Protection ADVANCE HUMANITY Naseem-Ur-Rehman.
Expanded program of Immunization (EPI) Introduction The Expanded Program on Immunization (EPI) was established in 1974 depending on the success of the.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) FIELD WORK 2 -Expanded Surveillance Report- -Measles.
Presentation on Field Work Careysburg District, Montserrado county By John S. Yarngrorble. DSO.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) Report on Basic FETP Field Project 2 By Ruth.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Expanded Program of Immunization (EPI). Definition It is program adopted by WHO since l974, it includes child immunization & vaccination of pregnant women.
Poliovirus Surveillance and Risks to Polio Eradication in India Dr. Hamid Jafari WHO-NPSP.
1 EPI services for migrant populations in Tak province.
Poliovirus Surveillance status of quality, actions to improve sensitivity WHO-India 15 March 2012.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
12 th Annual Meeting of The Measles & Rubella Initiative American Red Cross, Washington, DC September, 2013.
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) FIELD WORK 2 -Expanded Surveillance Report- -Measles.
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
World Health Organization Western Pacific Regional Office Expanded Programme on Immunization Measles Elimination in the Western Pacific Region 2007 Partners.
Module 5 Recording and monitoring administration of the Inactivated Polio Vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Complex Emergency Response: Are We Prepared? Lebanon Experience Seventh Global Measles Partners Meeting 27 – 28 th February 2007, Washington D.C. Dr. Mirza,
Maternal and Neonatal Tetanus Elimination (MNTE) in Kenya Dr Collins Tabu, National Vaccines and Immunization Program Ministry of Health, Kenya.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Targeted supplementary immunization
Dr. Munir Abdullah – EPI Manager
Overview of National Surveillance for Vaccine-Preventable Diseases
23 November, 2018 Update on measles & rubella surveillance in the WHO African Region – progress and challenges Dr Richard Luce WHO/IST-Central 5th African.
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
The Texas Child Care Immunization Assessment Survey
Presentation transcript:

Measles elimination Dr. As’ad Ramlawi Palestine.

Measles vaccination coverage in the last 15 years is more than 95%. Two doses, at 9 th month ( measles ) & at 15 th month ( MMR ).

Measles incidence rate in the last 6 years : YearMeasles

Measles Reporting 1.Clinical picture 2.IgM confirmation 3.Daily notification 4.Case investigation

Measles out Break In 1990, 1994, 1999, in small clusters From 1999 till now, NO Measles Out Break.

Measles Seroservey 1990 – 1995 ========= % immune response

Measles immune response during Al Aqsa Intifada Vaccine Negative W.B Gaza Total Equivocal W.B Gaza Total Positive W.B Gaza Total Measles 12.7% 31.6% 20.3%13.5% 12.1% 13.0%73.8% 56.3% 66.7% Rubella 2.5% 1.5% 2.1%0.0% 0.5% 0.2%97.5% 98.0% 97.7% Hep.B 5.5% 7.9% 6.5%1.4% 1.5% 1.4%93.1% 90.6% 92.1%

WHY Low immune response 1.Measles vaccine ?? 2.Screening Kits ?? 3.Cold chain ??

Cold chain affected By: 1.Electricity 2.Transportation 3.Political instability, Siege, Closure, Curfew

Measles National Plan WHO Goal Measles elimination Taking into consideration: 1.Measles vaccination low response 2.Measles high infectivity rate 3.Measles vaccine sensitivity

Micronutrient deficiencies Anemia Vitamin A for: - Children under 5 years old 22 % Vit. A deficiency 54 % Border line

Recommendation of the serosurvey 1.Carry out a measles vaccination campaign for all children between 9 months & 5 years of age 2.A sero-survey with a small sample should be carried out after three months after the end of the campaign. This will serve as an indicator for the sero-response

Recommendation Cont. 3. More attention should be paid to the cold chain. 4. The sero-survey results should be widely disseminated to all the health providers. 5. Training for all health personnel in the expanded program on immunization (EPI ) in general & cold chain in particular should be carried out.

Campaign carried out in 2004 for children between 9months – 60 months 1.Measles Vaccine 2.Vitamin A capsules 100,000 IU 9m – 12 m. 200,000 IU 12m – 60 m.

Mumps Outbreak Age affected 5 years – 25 years. Thousands of cases with some complication.

MMR campaign was conducted in years – 25 years. the number of vaccinated children were 650,000

The second serosurvey is in 2006 for the same targeted group of the first Measles campaign with 98 %immune response.

Polio

Estimated of Palestinian population for 2006 Total Population <1 year < 5 years < 15 years 3,512,822129, ,282 1,626,437

Vaccination Coverage OPV3 coverage is more than 90 % in the last 10 years.

OPV coverage in Palestine YearCoverageYearCoverage % % % % % % % % % %

Polio cases Last case was detected in One case wild polio virus One vaccine associated virus Last wild poliovirus isolate in 2002 ( Feb. August ) : Rafah, Gaza ( imported ).

NIDs Implemented since 1995 up to Two rounds yearly for children under 5 years old with > 95 % coverage.

Mopping up Is implemented since 2000 up to 2005 targeted for children under 5 years for certain areas selected by preventive medicine dept.

AFP surveillance Started in 1996 & performance indicators were achieved up to – 2004 indicators were not achieved due to Intifada ( invasions, closures, & restrictions) indicators were achieved again. Virus isolation not done in PNA areas.

Improving AFP Surveillance in 2005 Certificates of appreciation Increase sensitization among pediatrician. Meeting Frb Increasing zero-reporting sites to include major pediatricians from 22 to 32.

Environmental Surveillance Collect on monthly bases. Last wild poliovirus isolation was from : Rafah, Gaza,2002:imported, Egyptian strain total 190 samples: - West Bank Gaza 26.

Lessons learned 1.Additional activities for good surveillance is very important in planning & prevention ( serosurvey, environmental screening). 2.Better coordination ( UNICEF, MoH, WHO ) 3.Good preparation before starting

Lessons learned cont. 4. Media involvement 5. Community participation 6. Target groups should based on the really number of newborns in Palestine.

THANK YOU